Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5194776
Max Phase: Preclinical
Molecular Formula: C44H47FN8O8
Molecular Weight: 834.91
Associated Items:
ID: ALA5194776
Max Phase: Preclinical
Molecular Formula: C44H47FN8O8
Molecular Weight: 834.91
Associated Items:
Canonical SMILES: O=C1CCC(N2C(=O)c3cccc(NC(=O)CNCCCCCCCCC(=O)N4CCN(C(=O)c5cc(Cc6n[nH]c(=O)c7ccccc67)ccc5F)CC4)c3C2=O)C(=O)N1
Standard InChI: InChI=1S/C44H47FN8O8/c45-32-16-15-27(25-34-28-10-6-7-11-29(28)40(57)50-49-34)24-31(32)42(59)52-22-20-51(21-23-52)38(56)14-5-3-1-2-4-8-19-46-26-37(55)47-33-13-9-12-30-39(33)44(61)53(43(30)60)35-17-18-36(54)48-41(35)58/h6-7,9-13,15-16,24,35,46H,1-5,8,14,17-23,25-26H2,(H,47,55)(H,50,57)(H,48,54,58)
Standard InChI Key: FZFKGRYBBBKJLK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 834.91 | Molecular Weight (Monoisotopic): 834.3501 | AlogP: 3.30 | #Rotatable Bonds: 16 |
Polar Surface Area: 211.05 | Molecular Species: BASE | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 16 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.95 | CX Basic pKa: 8.63 | CX LogP: 2.85 | CX LogD: 1.78 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.10 | Np Likeness Score: -1.10 |
1. Pu C, Wang S, Luo D, Liu Y, Ma X, Zhang H, Yu S, Lan S, Huang Q, Deng R, He X, Li R.. (2022) Synthesis and biological evaluation of a tumor-selective degrader of PARP1., 69 [PMID:35780655] [10.1016/j.bmc.2022.116908] |
Source(1):